Literature DB >> 9559654

X-ray and spectrophotometric studies of the binding of proflavin to the S1 specificity pocket of human alpha-thrombin.

E Conti1, C Rivetti, A Wonacott, P Brick.   

Abstract

Proflavin can be used to study the interactions of inhibitors and substrates with thrombin by monitoring the changes in the visible absorption spectrum that occur on dye displacement. We have used microspectrophotometric methods to investigate the binding of proflavin to crystals of an alpha-thrombin-hirugen complex and have determined the structure by X-ray crystallography. The proflavin molecule binds in the S1 pocket of the enzyme with one of the amino groups hydrogen bonded to the carboxylate of Asp-189 while the protonated ring nitrogen is hydrogen bonded to the carbonyl of Gly-219. This result indicates that the proflavin displacement assay can be used to specifically monitor the binding of inhibitors to the S1 pocket.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9559654     DOI: 10.1016/s0014-5793(98)00235-x

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  4 in total

1.  Low dielectric response in enzyme active site.

Authors:  E L Mertz; L I Krishtalik
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 11.205

2.  A comparison of the pharmacophore identification programs: Catalyst, DISCO and GASP.

Authors:  Yogendra Patel; Valerie J Gillet; Gianpaolo Bravi; Andrew R Leach
Journal:  J Comput Aided Mol Des       Date:  2002 Aug-Sep       Impact factor: 3.686

3.  Protonation linked equilibria and apparent affinity constants: the thermodynamic profile of the alpha-chymotrypsin-proflavin interaction.

Authors:  Gilles Bruylants; René Wintjens; Yvan Looze; Christina Redfield; Kristin Bartik
Journal:  Eur Biophys J       Date:  2007-04-19       Impact factor: 1.733

4.  Measurement of Ligand-Target Residence Times by 1H Relaxation Dispersion NMR Spectroscopy.

Authors:  Thomas Moschen; Sarina Grutsch; Michael A Juen; Christoph H Wunderlich; Christoph Kreutz; Martin Tollinger
Journal:  J Med Chem       Date:  2016-11-29       Impact factor: 7.446

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.